Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
€ 0
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Gour Medical SA engages in the development and marketing of various veterinary solutions for companion animals. It provides cannabidiol-based solutions for pets under the WEEDLEY brand. The company was founded in 2014 and is based in Paris, France.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is 'expensive' on EV/EBITDA.
Data is available to registered users only
Buy
Sell